69 related articles for article (PubMed ID: 1592425)
21. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice.
Sipka S; Bráth E; Tóth FF; Aleksza M; Kulcsár A; Fábián A; Baráth S; Balogh P; Sipka S; Furka I; Mikó I
Transpl Immunol; 2006 Aug; 16(2):99-104. PubMed ID: 16860712
[TBL] [Abstract][Full Text] [Related]
22. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of poor CD3 response in head and neck cancer.
Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
[TBL] [Abstract][Full Text] [Related]
24. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
[TBL] [Abstract][Full Text] [Related]
25. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
26. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
27. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
28. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
Rabin BS; Johnson J; Claassen D
Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of M-cell-associated B and T cells in human Peyer's patches.
Farstad IN; Halstensen TS; Fausa O; Brandtzaeg P
Immunology; 1994 Nov; 83(3):457-64. PubMed ID: 7835971
[TBL] [Abstract][Full Text] [Related]
30. [The alternation of peripheral lymphocyte subsets in head and neck carcinoma].
Mitarai K; Tsukuda M; Mochimatsu I; Kubota A; Sawaki S
Gan No Rinsho; 1986 Jul; 32(8):849-54. PubMed ID: 3747146
[TBL] [Abstract][Full Text] [Related]
31. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
[TBL] [Abstract][Full Text] [Related]
32. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity.
Grage-Griebenow E; Lorenzen D; Fetting R; Flad HD; Ernst M
Eur J Immunol; 1993 Dec; 23(12):3126-35. PubMed ID: 7504990
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
[TBL] [Abstract][Full Text] [Related]
34. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
36. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
37. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
Dawson DE; Everts EC; Vetto RM; Burger DR
Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
[TBL] [Abstract][Full Text] [Related]
38. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
39. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
[TBL] [Abstract][Full Text] [Related]
40. An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes.
Böheim K; Denz H; Böheim C; Glassl H; Huber H
Arch Otorhinolaryngol; 1987; 244(2):127-32. PubMed ID: 2959247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
